X

Vous n'êtes pas connecté

Rubriques :

Maroc Maroc - DRUGS.COM - Clinical Trials News - 09/Aug 21:08

First Patients Enrolled in US Pivotal Study of AI-Based Image Analysis Module for Lung Cancer

SANTA CLARA, Calif., Aug. 9, 2024. Invenio Imaging, a leader in intraoperative fresh tissue imaging and artificial intelligence (AI), announced today the enrollment of the first patients in a US pivotal study of its AI-based image analysis module...

Articles similaires

Sorry! Image not available at this time

New AI model creates virtual colorations of cancer tissue for enhanced diagnostics

news.medical.net - 10/Sep 13:35

A recent study published in Nature Machine Intelligence introduces an advanced artificial intelligence (AI) model capable of creating virtual...

Sorry! Image not available at this time

Median Technologies Announces Pivotal REALITY Study of Its eyonis™ LCS Lung Cancer Diagnostic Met All Primary and Secondary Endpoints

healthtechzone.com - 29/Aug 15:45

Sorry! Image not available at this time

First Patient Enrolled in Phase 1b/2 Triplet Therapy Trial of REZLIDHIA in mIDH1 AML

drugs.com - 06/Sep 07:09

SOUTH SAN FRANCISCO, Calif., Sept. 5, 2024. Rigel Pharmaceuticals, a commercial stage biotechnology company focused on hematologic disorders and...

Sorry! Image not available at this time

First Patient Enrolled in Investigator-Sponsored Phase 2 Clinical Trial of Vidofludimus Calcium in Patients with Post COVID Syndrome

drugs.com - 05/Sep 04:09

NEW YORK, Sept. 4, 2024. Immunic, Inc., a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for...

Sorry! Image not available at this time

Arrowhead Pharmaceuticals Presents New Pivotal Phase 3 Data at ESC 2024 from PALISADE Study of Plozasiran in Patients with Familial Chylomicronemia Syndrome

drugs.com - 02/Sep 04:09

PASADENA, Calif.–(BUSINESS WIRE)–Sep. 2, 2024– Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced results from the Phase 3 PALISADE...

Sorry! Image not available at this time

Alternative Explanation Conditions Often Delay Lung Cancer Diagnosis

drugs.com - 15:09

WEDNESDAY, Sept. 11, 2024 -- Conditions offering alternative explanations for lung cancer symptoms are associated with increased diagnostic intervals,...

Sorry! Image not available at this time

Long-term conditions could delay lung cancer diagnosis

oncologynews.com.au - 03/Sep 11:54

A new study from researchers at Brighton and Sussex Medical School (BSMS), in the UK< reveals that patients living with certain long-term health...

Sorry! Image not available at this time

Novel Computational Pathology-Based TROP2 Biomarker for Datopotamab Deruxtecan Was Predictive of Clinical Outcomes in Patients With Non-Small Cell Lung Cancer in TROPION-Lung01 Phase III Trial

drugs.com - 08/Sep 06:09

September 8, 2024 -- Results from an exploratory analysis of the TROPION-Lung01 Phase III trial showed TROP2 as measured by AstraZeneca’s...

Sorry! Image not available at this time

Novel Computational Pathology-Based TROP2 Biomarker for Datopotamab Deruxtecan Was Predictive of Clinical Outcomes in Patients With Non-Small Cell Lung Cancer in TROPION-Lung01 Phase III Trial

drugs.com - 08/Sep 06:09

September 8, 2024 -- Results from an exploratory analysis of the TROPION-Lung01 Phase III trial showed TROP2 as measured by AstraZeneca’s...

Sorry! Image not available at this time

AI Transforms Gene Mutations Prediction in Lung Cancer

medindia.net - 09/Sep 03:52

Artificial intelligence revolutionizes gene mutation prediction in lung cancer, offering more accurate, faster insights for personalized treatment...

Les derniers communiqués